Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI

Autores da FMUP

• João Pedro Melo Marques Pinho Ferreira

  Autor

Participantes de fora da FMUP

• Pitt, B
• Zannad, F

Unidades de investigação

• Cirurgia e Fisiologia

• Laboratório Associado RISE- Rede de Investigação em Saúde

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Keywords

• Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Spironolactone; enalapril; eplerenone; mineralocorticoid antagonist; ramipril; sacubitril plus valsartan; mineralocorticoid antagonist; spironolactone; Article; cardiovascular mortality; evidence based medicine; heart failure; heart failure with reduced ejection fraction; heart infarction; human; complication